Explore More Than Just This Free Article

This article is a glimpse of the exclusive insights we provide daily to industry leaders. Dive deeper into our industry-specific reports and uncover the strategic information you need.

American Cleaning Institute addresses FDA on Topical Antiseptics Program; organization seeks clearer feedback on GRAS/E expectations at Over-The-Counter Monograph Drug User Fee Program meeting

November 20, 2024 (press release) –

  • Comments emphasize the need for clearer Agency feedback to industry and a pathway for dispute resolution

The American Cleaning Institute (ACI) provided comments to the U.S. Food and Drug Administration (FDA) at their Over-The-Counter Monograph Drug User Fee Program (OMUFA) Reauthorization Public Meeting on Wednesday, November 20 at the FDA Headquarters at the White Oak Campus.

Dr. James Kim, ACI Senior Vice President, Science & Regulatory Affairs, provided comments regarding the Topical Antiseptics Program, focusing on getting clearer feedback from FDA on GRAS/E expectations, and a pathway for dispute resolution.

Dr. Patrizia Cavazzoni (FDA Center Director, CDER) and Dr. Theresa Michele (FDA Director, Office of Non-Prescription Drugs, CDER) kicked off the meeting by providing an overview of OMUFA and the reauthorization process. The reauthorization process was initiated by a public meeting in September 2023, where ACI provided comments and participated in the subsequent industry-FDA discussions.

For this meeting, marking the completion and agreement on the OMUFA goals for 2026-2030 (OMUFA II), FDA invited perspectives from the regulated community, as well as academic and advocacy perspectives. The OMUFA Performance Goals and Procedures will be transmitted to Congress for approval in early 2025.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo with Jason
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.